Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Hansa Raises $121m To Fund Idefirix Launch

Big Plans For Antibody-Cleaving Enzyme

Jul 09 2020

• By Kevin Grogan

Flag_Sweden — Sweden's Hansa Attracts Investors • Source: Shutterstock

Related Content

Sarepta’s Gene Therapy Impresses In Limb-Girdle Muscular Dystrophy

Jun 09 2020

Related Companies

Hansa Biopharma AB

Sarepta Therapeutics, Inc.

Additional Topics

Financing Rare Diseases Deals Commercial Companies Gene Therapy Launches BioPharmaceutical

More from Financing

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.